Effect of transcatheter (via femoral artery) aortic valve implantation on the platelet count and its consequences

American Journal of Cardiology

Volumn 111, Issue 11, 2013, Pages 1619-1624

  Gallet, Romain ^a   Seemann, Aurelien ^a   Yamamoto, Masanori ^a   Hayat, Delphine ^a   Mouillet, Gauthier ^a   Monin, Jean Luc ^a   Gueret, Pascal ^a   Couetil, Jean Paul ^a   Dubois Randé, Jean Luc ^a   Teiger, Emmanuel ^a   Lim, Pascal ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AORTA STENOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; FEMALE; FEMORAL ARTERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTHESIS LOOSENING; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT; TRANSCATHETER AORTIC VALVE IMPLANTATION; X RAY;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; FRANCE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE; THROMBOSIS;

EID: 84877832743     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.01.332     Document Type: Article

References (29)

1. A. Cribier, H. Eltchaninoff, C. Tron, F. Bauer, C. Agatiello, D. Nercolini, S. Tapiero, P.Y. Litzler, J.P. Bessou, and V. Babaliaros Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience J Am Coll Cardiol 47 2006 1214 1223
2. J. Rodes-Cabau, J.G. Webb, A. Cheung, J. Ye, E. Dumont, C.M. Feindel, M. Osten, M.K. Natarajan, J.L. Velianou, G. Martucci, B. DeVarennes, R. Chisholm, M.D. Peterson, S.V. Lichtenstein, F. Nietlispach, D. Doyle, R. DeLarochelliere, K. Teoh, V. Chu, A. Dancea, K. Lachapelle, A. Cheema, D. Latter, and E. Horlick Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience J Am Coll Cardiol 55 2010 1080 1090
3. C.R. Smith, M.B. Leon, M.J. Mack, D.C. Miller, J.W. Moses, L.G. Svensson, E.M. Tuzcu, J.G. Webb, G.P. Fontana, R.R. Makkar, M. Williams, T. Dewey, S. Kapadia, V. Babaliaros, V.H. Thourani, P. Corso, A.D. Pichard, J.E. Bavaria, H.C. Herrmann, J.J. Akin, W.N. Anderson, D. Wang, and S.J. Pocock Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
4. J.G. Webb, M. Chandavimol, C.R. Thompson, D.R. Ricci, R.G. Carere, B.I. Munt, C.E. Buller, S. Pasupati, and S. Lichtenstein Percutaneous aortic valve implantation retrograde from the femoral artery Circulation 113 2006 842 850
5. H. Eltchaninoff, A. Prat, M. Gilard, A. Leguerrier, D. Blanchard, G. Fournial, B. Iung, P. Donzeau-Gouge, C. Tribouilloy, J.L. Debrux, A. Pavie, and P. Gueret Transcatheter aortic valve implantation: early results of the FRANCE (French Aortic National CoreValve and Edwards) registry Eur Heart J 32 2010 191 197
6. M. Gilard, H. Eltchaninoff, B. Iung, P. Donzeau-Gouge, K. Chevreul, J. Fajadet, P. Leprince, A. Leguerrier, M. Lievre, A. Prat, E. Teiger, T. Lefevre, D. Himbert, D. Tchetche, D. Carrie, B. Albat, A. Cribier, G. Rioufol, A. Sudre, D. Blanchard, F. Collet, P. Dos Santos, N. Meneveau, A. Tirouvanziam, C. Caussin, P. Guyon, J. Boschat, H. Le Breton, F. Collart, R. Houel, S. Delpine, G. Souteyrand, X. Favereau, P. Ohlmann, V. Doisy, G. Grollier, A. Gommeaux, J.P. Claudel, F. Bourlon, B. Bertrand, E. Van Belle, and M. Laskar Registry of transcatheter aortic-valve implantation in high-risk patients N Engl J Med 366 2012 1705 1715
7. M. Gotzmann, A. Pljakic, W. Bojara, M. Lindstaedt, A. Ewers, A. Germing, and A. Mugge Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response Am Heart J 162 2011 238 245
8. N. Piazza, E. Grube, U. Gerckens, P. den Heijer, A. Linke, O. Luha, A. Ramondo, G. Ussia, P. Wenaweser, S. Windecker, J.C. Laborde, P. de Jaegere, and P.W. Serruys Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve Revalving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval EuroIntervention 4 2008 242 249
9. R. Zahn, U. Gerckens, E. Grube, A. Linke, H. Sievert, H. Eggebrecht, R. Hambrecht, S. Sack, K.E. Hauptmann, G. Richardt, H.R. Figulla, and J. Senges Transcatheter aortic valve implantation: first results from a multi-centre real-world registry Eur Heart J 32 2010 198 204
10. R.J. Nuis, N.M. Van Mieghem, C.J. Schultz, A. Moelker, R.M. van der Boon, R.J. van Geuns, A. van der Lugt, P.W. Serruys, J. Rodes-Cabau, R.T. van Domburg, P.J. Koudstaal, and P.P. de Jaegere Frequency and causes of stroke during or after transcatheter aortic valve implantation Am J Cardiol 109 2012 1637 1643
11. R.J. Nuis, N.M. Van Mieghem, A. Tzikas, N. Piazza, A.M. Otten, J. Cheng, R.T. van Domburg, M. Betjes, P.W. Serruys, and P.P. de Jaegere Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation Catheter Cardiovasc Interv 77 2010 881 889
12. P. Wenaweser, T. Pilgrim, N. Roth, A. Kadner, S. Stortecky, B. Kalesan, F. Meuli, L. Bullesfeld, A.A. Khattab, C. Huber, B. Eberle, G. Erdos, B. Meier, P. Juni, T. Carrel, and S. Windecker Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes Am Heart J 161 2011 1114 1124
13. L. Hilker, M. Wodny, M. Ginesta, H.G. Wollert, and L. Eckel Differences in the recovery of platelet counts after biological aortic valve replacement Interact Cardiovasc Thorac Surg 8 2009 70 73
14. A. Repossini, D. Bloch, C. Muneretto, P. Piccoli, G. Bisleri, and S. Beholz Platelet reduction after stentless pericardial aortic valve replacement Interact Cardiovasc Thorac Surg 14 2012 434 438
15. P. Steele, H. Weily, H. Davies, G. Ppppas, and E. Genton Platelet survival time following aortic valve replacement Circulation 51 1975 358 362
16. M. Yamamoto, K. Meguro, G. Mouillet, E. Bergoend, J.L. Monin, P. Lim, J.L. Dubois-Rande, and E. Teiger Comparison of effectiveness and safety of transcatheter aortic valve implantation in patients aged >/=90 years versus <90 years Am J Cardiol 110 2012 1156 1163
17. L. Buellesfeld, P. Wenaweser, U. Gerckens, R. Mueller, B. Sauren, G. Latsios, B. Zickmann, G. Hellige, S. Windecker, and E. Grube Transcatheter aortic valve implantation: predictors of procedural success - the Siegburg-Bern experience Eur Heart J 31 2010 984 991
18. J.G. Webb, S. Pasupati, K. Humphries, C. Thompson, L. Altwegg, R. Moss, A. Sinhal, R.G. Carere, B. Munt, D. Ricci, J. Ye, A. Cheung, and S.V. Lichtenstein Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis Circulation 116 2007 755 763
19. A. Cribier, H. Eltchaninoff, A. Bash, N. Borenstein, C. Tron, F. Bauer, G. Derumeaux, F. Anselme, F. Laborde, and M.B. Leon Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description Circulation 106 2002 3006 3008
20. M.B. Leon, N. Piazza, E. Nikolsky, E.H. Blackstone, D.E. Cutlip, A.P. Kappetein, M.W. Krucoff, M. Mack, R. Mehran, C. Miller, M.A. Morel, J. Petersen, J.J. Popma, J.J. Takkenberg, A. Vahanian, G.A. van Es, P. Vranckx, J.G. Webb, S. Windecker, and P.W. Serruys Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium J Am Coll Cardiol 57 2011 253 269
21. A. De Labriolle, L. Bonello, G. Lemesle, P. Roy, D.H. Steinberg, Z. Xue, W.O. Suddath, L.F. Satler, K.M. Kent, A.D. Pichard, J. Lindsay, and R. Waksman Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors Eur Heart J 31 2010 1079 1087
22. E. Grube, J.C. Laborde, U. Gerckens, T. Felderhoff, B. Sauren, L. Buellesfeld, R. Mueller, M. Menichelli, T. Schmidt, B. Zickmann, S. Iversen, and G.W. Stone Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study Circulation 114 2006 1616 1624
23. Z. Parvez, and R. Moncada Nonionic contrast medium: effects on blood coagulation and complement activation in vitro Angiology 37 1986 358 364
24. R. Badr Eslam, T. Gremmel, A. Schneller, M. Stegfellner, A. Kaider, C. Mannhalter, I. Lang, and S. Panzer High levels of platelet-monocyte aggregates after valve replacement for aortic stenosis: relation to soluble P-selectin and P-selectin glycoprotein ligand-1 genes Thromb Res 129 2011 453 458
25. I.R. Goldsmith, A.D. Blann, R.L. Patel, and G.Y. Lip Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction Heart 83 2000 577 578
26. I.R. Goldsmith, A.D. Blann, R.L. Patel, and G.Y. Lip Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen Am J Cardiol 87 2001 107 110
27. A. Leguyader, R. Watanabe, J. Berbe, A. Boumediene, M. Cogne, and M. Laskar Platelet activation after aortic prosthetic valve surgery Interact Cardiovasc Thorac Surg 5 2006 60 64
28. M. Nobili, J. Sheriff, U. Morbiducci, A. Redaelli, and D. Bluestein Platelet activation due to hemodynamic shear stresses: damage accumulation model and comparison to in vitro measurements ASAIO J 54 2008 64 72
29. J.M. Sinning, A.C. Scheer, V. Adenauer, A. Ghanem, C. Hammerstingl, R. Schueler, C. Muller, M. Vasa-Nicotera, E. Grube, G. Nickenig, and N. Werner Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation Eur Heart J 33 2012 1459 1468